Literature DB >> 29525912

Dialytic interval and the timing of electrocardiographic screening for subcutaneous cardioverter-defibrillator placement in chronic hemodialysis patients.

Cindy You1, Shishir Sharma1, Aakash Bavishi1, Christopher A Groh1, Yazan Alia1, Basil Saour1, Rod Passman2,3.   

Abstract

BACKGROUND: Hemodialysis (HD) patients have a high risk of sudden death but limited vascular access and high complication rates from transvenous implantable cardioverter-defibrillators (ICDs). Subcutaneous ICDs (S-ICD) may be an alternative, but dynamic ECG changes may result in inappropriate shocks. This study aims to define the screen failure rate for S-ICD in patients pre- and post-HD.
METHODS: ECG waveforms were obtained using electrodes mimicking the S-ICD sensing vectors in an unselected test group of chronic HD patients and a control group of ICD-eligible non-dialysis patients. Participants passed screening if their QRS and T-waves fit within the screening template in supine and standing positions in any lead. Test group participants were screened before and after HD and control group patients were screened at two separate time points. HD patients were stratified into the four following groups: (A) passed screening before and after HD, (B) failed screening before but passed after HD, (C) passed screening before but failed after HD, and (D) failed screening before and after HD. Patients in group A passed the screening for ICD implantation, and patients in groups B, C, and D failed the screening for ICD implantation. Control patients were similarly classified by pass/fail status at the two assessment points.
RESULTS: Of the 76 patients enrolled, 51 were HD patients and 25 were controls. Of the 51 HD patients, 43 (84%) were in group A, four participants (8%) were in group B, one (2%) was in group C, and three participants (6%) were in group D. There were no differences in any of the clinical or demographic variables between the pass and fail test HD groups. None of the 25 controls failed the screening at either time point (p = 0.047 vs HD patients).
CONCLUSIONS: Overall, HD patients were more likely to fail S-ICD screening compared to non-HD patients (16 v 0%, p = 0.047) and are more likely to do so prior to HD. Patients on HD should be screened at multiple time points around the dialytic interval to reduce the risk of inappropriate shocks.

Entities:  

Keywords:  End-stage renal diseases; Hemodialysis; Inappropriate shocks; Subcutaneous ICD; T-wave oversensing

Mesh:

Year:  2018        PMID: 29525912     DOI: 10.1007/s10840-018-0343-1

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.900


  20 in total

1.  Effect of end-stage renal failure and hemodialysis on mortality rates in implantable cardioverter-defibrillator recipients.

Authors:  Haitham Hreybe; Eathar Razak; Samir Saba
Journal:  Pacing Clin Electrophysiol       Date:  2007-09       Impact factor: 1.976

2.  Safety and efficacy of a totally subcutaneous implantable-cardioverter defibrillator.

Authors:  Raul Weiss; Bradley P Knight; Michael R Gold; Angel R Leon; John M Herre; Margaret Hood; Mayer Rashtian; Mark Kremers; Ian Crozier; Kerry L Lee; Warren Smith; Martin C Burke
Journal:  Circulation       Date:  2013-08-27       Impact factor: 29.690

Review 3.  Clinical epidemiology of cardiovascular disease in chronic renal disease.

Authors:  R N Foley; P S Parfrey; M J Sarnak
Journal:  Am J Kidney Dis       Date:  1998-11       Impact factor: 8.860

4.  Challenges of ECG monitoring and ECG interpretation in dialysis units.

Authors:  Dimitrios Poulikakos; Marek Malik
Journal:  J Electrocardiol       Date:  2016-07-28       Impact factor: 1.438

5.  Primary prevention implantable cardioverter defibrillators in end-stage kidney disease patients on dialysis: a matched cohort study.

Authors:  Patrick H Pun; Anne S Hellkamp; Gillian D Sanders; John P Middleton; Stephen C Hammill; Hussein R Al-Khalidi; Lesley H Curtis; Gregg C Fonarow; Sana M Al-Khatib
Journal:  Nephrol Dial Transplant       Date:  2014-11-17       Impact factor: 5.992

6.  Trends in the use and outcomes of implantable cardioverter-defibrillators in patients undergoing dialysis in the United States.

Authors:  David M Charytan; Amanda R Patrick; Jun Liu; Soko Setoguchi; Charles A Herzog; M Alan Brookhart; Wolfgang C Winkelmayer
Journal:  Am J Kidney Dis       Date:  2011-06-12       Impact factor: 8.860

7.  Noninvasive potassium determination using a mathematically processed ECG: proof of concept for a novel "blood-less, blood test".

Authors:  John J Dillon; Christopher V DeSimone; Yehu Sapir; Virend K Somers; Jennifer L Dugan; Charles J Bruce; Michael J Ackerman; Samuel J Asirvatham; Bryan L Striemer; Jan Bukartyk; Christopher G Scott; Kevin E Bennet; Susan B Mikell; Dorothy J Ladewig; Emily J Gilles; Amir Geva; Dan Sadot; Paul A Friedman
Journal:  J Electrocardiol       Date:  2014-10-18       Impact factor: 1.438

Review 8.  QT interval dispersion in dialysis patients.

Authors:  Vin-Cent Wu; Lian-Yu Lin; Kwan-Dun Wu
Journal:  Nephrology (Carlton)       Date:  2005-04       Impact factor: 2.506

9.  Which patients are not suitable for a subcutaneous ICD: incidence and predictors of failed QRS-T-wave morphology screening.

Authors:  Louise R A Olde Nordkamp; Joppe L F Warnaars; Kirsten M Kooiman; Joris R de Groot; Boudewijn R A M Rosenmöller; Arthur A M Wilde; Reinoud E Knops
Journal:  J Cardiovasc Electrophysiol       Date:  2014-01-07

10.  Clinical characteristics and in-hospital outcome of patients with end-stage renal disease on dialysis referred for implantable cardioverter-defibrillator implantation.

Authors:  Atul Aggarwal; Yongfei Wang; John S Rumsfeld; Jeptha P Curtis; Paul A Heidenreich
Journal:  Heart Rhythm       Date:  2009-08-05       Impact factor: 6.343

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.